We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Through-Wave Ultrasound Shown To Be Effective for Breast Imaging and Biopsy

By Biotechdaily staff writers
Posted on 11 Dec 2007
A real-time through-wave ultrasound imaging system that uses the diffractive properties of sound combined with holography (HU) to create highly-detailed, three-dimensional images of breast tissue, is now equipped for image-guided biopsy. More...


Advanced Imaging Technologies (Richland, WA, USA) reported that the Aria Breast Imaging system (BIS) has been clinically proven to provide superior views of the breast tissue, especially dense tissue, while providing better data for enhanced diagnostic decision-making. The automated system's image-guidance for biopsy was recently demonstrated at the annual meeting of the Radiological Society of North America (RSNA) November 25-29, 2007, in Chicago, IL, USA.

Until now, women with dense breast tissue have had few options, as mammography is ineffective for dense tissue. This is significant given the link between tissue density and breast cancer documented in a study published in the January 18, 2007, issue of the New England Journal of Medicine (NEJM).

The Aria BIS effectively penetrates dense tissue, is automated with whole-breast presentation capabilities, and provides high spatial and contrast resolution. Moreover, the system allows for retrieval of earlier comparative studies for quick cross-correlation with known landmarks for year-to-year comparison.

"Our technology has proven to have superior spatial and contrast resolution, especially in dense tissue,” said Jeanette Griscavage-Ennis, Ph.D., manager, clinical applications. "The data we capture is saturated with critical information that is important for diagnostic procedures such as biopsy. Our real-time image-guidance capabilities provide physicians with precision for improved biopsy accuracy.”

Breast imaging has become a multimodality process intended to improve detection, diagnosis and staging of breast cancer. The result is earlier detection and improved outcomes for thousands of women. However, use of multiple modalities has real economic implications for workflow and efficiency. Low reimbursement rates make it difficult for imaging centers to stay financially sound and although demand for breast imaging services has increased, the numbers of imaging clinics has decreased.

Minimally operator dependent, the system combines the critical elements of multiple modalities into a single system that integrates easily into the patient work-up while improving workflow and efficiency. The system is picture archiving and communication system (PACS)/Digital Imaging and Communications in Medicine
(DiCOM)-compliant and features a flexible workstation that interfaces easily with multiple imaging and reporting systems.

The Aria BIS is U.S. Food and Drug Demonstration- (FDA)-cleared for breast imaging and image-guided breast biopsy.


Related Links:
Advanced Imaging Technologies

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.